180 Life Sciences (ATNF) has had the highest return since August 1, 2025 by a small-cap US stock, returning 245.9%.
| ASSET | % RETURN |
|---|---|
180 Life Sciences (ATNF) | 245.95% |
Zepp Health (ZEPP) | 169.61% |
Advent Technologies (ADNWW) | 155.32% |
GCM Grosvenor (GCMGW) | 152.1% |
Jyong Biotech Ltd Ordinary Shares (MENS) | 112.01% |
Telos (TLS) | 109.6% |
Ondas (ONDS) | 109.27% |
Y mAbs Therapeutics (YMAB) | 93.41% |
Aveanna Healthcare (AVAH) | 86.12% |
I-Mab (IMAB) | 70.35% |
Tilray (TLRY) | 69.73% |
Tonix Pharmaceuticals (TNXP) | 67.3% |
NioCorp Developments Ltd Common Stock (NB) | 67.28% |
Rigel Pharmaceuticals (RIGL) | 67.17% |
International Money Express (IMXI) | 66.78% |
Health In Tech, Inc Class A Common Stock (HIT) | 66.5% |
Holley (HLLY) | 65.37% |
Claritev (CTEV) | 64.79% |
Mativ (MATV) | 62.4% |
Jumia Technologies (JMIA) | 62.19% |
Myriad Genetics (MYGN) | 60.37% |
Backblaze (BLZE) | 60.06% |
Steelcase (SCS) | 58.57% |
Emergent Biosolutions (EBS) | 57.14% |
Gevo (GEVO) | 54.26% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
